Désirée A M van Oorschot (Desirée Van Oorschot, Desiree Van Oorschot, Desirée A M van Oorschot, Désirée van Oorschot)

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 23

Top Topics

Randomized Controlled Trial

Respiratory Syncytial Virus

Top Venues

Human vaccines & immunotherapeutics

Infectious diseases and therapy

Infectious disease reports

This page only lists publications with an associated author ORCID identifier.

Publications

Ru Han, Peter Franz M San Martin, Nurilign Ahmed, Adriana Guzmán-Holst, Ahmed Mohy, Thatiana de Jesus Pereira Pinto, Bruna M G de Veras, Jorge A Gomez, Gyneth Lourdes Bibera, Désirée A M van Oorschot
Modelling the Public Health Burden of Herpes Zoster and the Impact of Adjuvanted Recombinant Zoster Vaccine in Five Selected Countries in Southeast Asia. Infectious diseases and therapy 13 (4) (2024)
Jorge A Gomez, Otávio Cintra, Arnas Berzanskis, Salma Pacheco, Henny Jaswantlal, Abdelkader El Hasnaoui, Désirée A M van Oorschot, Adriana Guzman-Holst
Burden of Disease Due to Respiratory Syncytial Virus in Adults in Five Middle-Income Countries. Infectious disease reports 16 (4) (2024)
Ru Han, Peter Franz M San Martin, Nurilign Ahmed, Adriana Guzmán-Holst, Ahmed Mohy, Thatiana de Jesus Pereira Pinto, Bruna M G de Veras, Jorge A Gomez, Gyneth Lourdes Bibera, Désirée A M van Oorschot
Modelling the Public Health Burden of Herpes Zoster and the Impact of Adjuvanted Recombinant Zoster Vaccine in Five Selected Countries in Southeast Asia. Infectious diseases and therapy 13 (4) (2024)
Ru Han, Peter Franz M San Martin, Nurilign Ahmed, Adriana Guzmán-Holst, Ahmed Mohy, Thatiana de Jesus Pereira Pinto, Bruna M G de Veras, Jorge A Gomez, Gyneth Lourdes Bibera, Désirée A M van Oorschot
Modelling the Public Health Burden of Herpes Zoster and the Impact of Adjuvanted Recombinant Zoster Vaccine in Five Selected Countries in Southeast Asia. Infectious diseases and therapy 13 (4) (2024)
Ru Han, Peter Franz M San Martin, Nurilign Ahmed, Adriana Guzmán-Holst, Ahmed Mohy, Thatiana de Jesus Pereira Pinto, Bruna M G de Veras, Jorge A Gomez, Gyneth Lourdes Bibera, Désirée A M van Oorschot
Modelling the Public Health Burden of Herpes Zoster and the Impact of Adjuvanted Recombinant Zoster Vaccine in Five Selected Countries in Southeast Asia. Infectious diseases and therapy (2024)
Jorge A Gomez, Otávio Cintra, Arnas Berzanskis, Salma Pacheco, Henny Jaswantlal, Abdelkader El Hasnaoui, Désirée A M van Oorschot, Adriana Guzman-Holst
Burden of Disease Due to Respiratory Syncytial Virus in Adults in Five Middle-Income Countries. Infectious disease reports 16 (4) (2024)
Ru Han, Peter Franz M San Martin, Nurilign Ahmed, Adriana Guzmán-Holst, Ahmed Mohy, Thatiana de Jesus Pereira Pinto, Bruna M G de Veras, Jorge A Gomez, Gyneth Lourdes Bibera, Désirée A M van Oorschot
Modelling the Public Health Burden of Herpes Zoster and the Impact of Adjuvanted Recombinant Zoster Vaccine in Five Selected Countries in Southeast Asia. Infectious diseases and therapy 13 (4) (2024)
Jorge A Gomez, Otávio Cintra, Arnas Berzanskis, Salma Pacheco, Henny Jaswantlal, Abdelkader El Hasnaoui, Désirée A M van Oorschot, Adriana Guzman-Holst
Burden of Disease Due to Respiratory Syncytial Virus in Adults in Five Middle-Income Countries. Infectious disease reports 16 (4) (2024)
Ru Han, Peter Franz M San Martin, Nurilign Ahmed, Adriana Guzmán-Holst, Ahmed Mohy, Thatiana de Jesus Pereira Pinto, Bruna M G de Veras, Jorge A Gomez, Gyneth Lourdes Bibera, Désirée A M van Oorschot
Modelling the Public Health Burden of Herpes Zoster and the Impact of Adjuvanted Recombinant Zoster Vaccine in Five Selected Countries in Southeast Asia. Infectious diseases and therapy 13 (4) (2024)
Ru Han, Jorge A Gomez, Bruna M G de Veras, Thatiana de Jesus Pereira Pinto, Adriana Guzmán-Holst, Javier Nieto Guevara, Désirée A M van Oorschot
How large could the public health impact of introducing recombinant zoster vaccination for people aged ≥50 years in five Latin American countries be? Human vaccines & immunotherapeutics 19 (1) (2023)
Ru Han, Jorge A Gomez, Bruna M G de Veras, Thatiana de Jesus Pereira Pinto, Adriana Guzmán-Holst, Javier Nieto Guevara, Désirée A M van Oorschot
How large could the public health impact of introducing recombinant zoster vaccination for people aged ≥50 years in five Latin American countries be? Human vaccines & immunotherapeutics 19 (1) (2023)
Ru Han, Jorge A Gomez, Bruna M G de Veras, Thatiana de Jesus Pereira Pinto, Adriana Guzmán-Holst, Javier Nieto Guevara, Désirée A M van Oorschot
How large could the public health impact of introducing recombinant zoster vaccination for people aged ≥50 years in five Latin American countries be? Human vaccines & immunotherapeutics (2023)
Ru Han, Jorge A Gomez, Bruna M G de Veras, Thatiana de Jesus Pereira Pinto, Adriana Guzmán-Holst, Javier Nieto Guevara, Désirée A M van Oorschot
How large could the public health impact of introducing recombinant zoster vaccination for people aged ≥50 years in five Latin American countries be? Human vaccines & immunotherapeutics 19 (1) (2023)
Ru Han, Jorge A Gomez, Bruna M G de Veras, Thatiana de Jesus Pereira Pinto, Adriana Guzmán-Holst, Javier Nieto Guevara, Désirée A M van Oorschot
How large could the public health impact of introducing recombinant zoster vaccination for people aged ≥50 years in five Latin American countries be? Human vaccines & immunotherapeutics 19 (1) (2023)
Adriana Guzmán-Holst, Jorge A Gomez, Otávio Cintra, Désirée A M van Oorschot, Nicolas Jamet, Javier Nieto Guevara
Assessing the Underestimation of Adult Pertussis Disease in Five Latin American Countries. Infectious diseases and therapy (2023)
Ru Han, Jorge A Gomez, Bruna M G de Veras, Thatiana de Jesus Pereira Pinto, Adriana Guzmán-Holst, Javier Nieto Guevara, Désirée A M van Oorschot
How large could the public health impact of introducing recombinant zoster vaccination for people aged ≥50 years in five Latin American countries be? Human vaccines & immunotherapeutics 19 (1) (2023)
Enrique Chacon-Cruz, Erika Zoe Lopatynsky-Reyes, Gloria Huerta-Garcia, Maria Yolanda Cervantes-Apolinar, Adriana Guzmán-Holst, Désirée A M van Oorschot
Economic burden of meningococcal disease in children and adolescents in Tijuana, Mexico. Human vaccines & immunotherapeutics (2022)
Alen Marijam, Ekaterina Safonova, Mikhail Scherbakov, Evgeniy Shpeer, Désirée A M van Oorschot, Alla Rudakova, Vladimir Tatochenko, Nikolay Briko
Cost effectiveness and budget impact of universal varicella vaccination in Russia. Human vaccines & immunotherapeutics 18 (5) (2022)
Désirée A M van Oorschot, Hilde Vroling, Eveline M Bunge, John D Diaz-Decaro, Desmond Curran, Barbara P Yawn
A systematic literature review of herpes zoster incidence worldwide. Human vaccines & immunotherapeutics 17 (6) (2021)
Desmond Curran, Andrea Callegaro, Kyle Fahrbach, Binod Neupane, Hilde Vroling, Désirée A M van Oorschot, Barbara P Yawn
Meta-Regression of Herpes Zoster Incidence Worldwide. Infectious diseases and therapy (2021)
Desmond Curran, Désirée A M van Oorschot, Sean Matthews, Johannes Hain, Ahmed Ehab Salem, Magdalena Schwarz
Long-term efficacy data for the recombinant zoster vaccine: impact on public health and cost effectiveness in Germany. Human vaccines & immunotherapeutics 17 (12) (2021)
Dapeng Yin, Désirée A M van Oorschot, Ning Jiang, Alen Marijam, Debasish Saha, Zhenhua Wu, Haiwen Tang, John D Diaz-Decaro, Phil Watson, Xueqiong Xie, Yifan Ren, Yu He, Yang Feng
A systematic literature review to assess the burden of herpes zoster disease in China. Expert review of anti-infective therapy 19 (2) (2020)
Désirée A M van Oorschot, Manjit Hunjan, Benjamin Bracke, Stéphane Lorenc, Desmond Curran, Helen Starkie-Camejo
Public health impact model estimating the impact of introducing an adjuvanted recombinant zoster vaccine into the UK universal mass vaccination programme. BMJ open 9 (5) (2019)